Private equity firm Advent International has wholly acquired Industria Chimica Emiliana (ICE), an Italian company specialising in the production of cholic acid used for the treatment of gastric and liver diseases.
Backers close a $18.6m round started in 2015 with an initial $10.6m capital injection
GP invests via its Nordic Capital Fund IX, which held a final close on €4.3bn in May 2018
Abalos Therapeutics is a biotechnology company focused on developing immuno-oncology therapeutics
Existing management team will lead the company's future growth and development